WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

4.20.26

Wilson Sonsini Advises Novo Holdings on Route 92 Medical’s $50 Million Growth Financing
On April 7, 2026, Route 92 Medical, a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, announced a $50 million growth financing led by Novo Holdings. New investor Sectoral Asset Management and existing investors U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group joined in the financing round. Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction.
Client Highlights

4.20.26

Wilson Sonsini Advises Slash on $100 Million Series C
On April 16, 2026, Slash Financial, Inc., a banking platform built for modern businesses, announced it has raised $100 million in a Series C funding round, valuing the company at $1.4 billion. The round was led by Ribbit Capital and included Khosla Ventures, Goodwater Capital, New Enterprise Associates, and Y Combinator. This latest funding elevates Slash to unicorn status and brings the total amount of capital raised to over $160 million. Wilson Sonsini Goodrich & Rosati advised Slash on the transaction.
Client Highlights

4.14.26

Wilson Sonsini Advises Atlas on $40 Million Series C
On April 14, 2026, Atlas, a first-of-its-kind, members-only concierge service and charge card focused on delivering access to coveted experiences through a seamless spending experience, announced its $40 million funding round, with a total valuation of $420 million. The funding round was led by solo venture capitalist Elad Gil and Verified Capital and included 01 Advisors, Marathon Management Partners, and others. Wilson Sonsini Goodrich & Rosati advised Atlas on the transaction.
Client Highlights

3.10.26

Wilson Sonsini Advises Sandbar on $23 Million Series A
On March 10, 2026, New York City-based Sandbar, an AI-enabled wearables company, announced it has raised $23 million in a Series A funding round led by Adjacent and Kindred Ventures, bringing total funding to $36 million. Wilson Sonsini Goodrich & Rosati advised Sandbar on the transaction.
Client Highlights

10.09.25

Wilson Sonsini Advises Reflection AI on $2 Billion Funding Round
On October 9, 2025, Reflection AI, a company developing superintelligent autonomous systems, announced the completion of a $2 billion funding round led by NVIDIA, with participation from Disruptive Technology Advisors, former Google CEO Eric Schmidt, Citi, and DST, as well as existing investors Lightspeed and Sequoia. Wilson Sonsini Goodrich & Rosati advised Reflection AI on the transaction.
Client Highlights

1.24.25

Wilson Sonsini Advises Micron on $1 Billion Senior Notes Offering
On January 16, 2025, Micron Technology, Inc., settled its offering of $1 billion aggregate principal amount of 5.80 percent senior notes due 2035. Micron intends to use the net proceeds from the sale of the notes to pay the redemption price of its outstanding 4.975 percent senior notes due 2026 and for general corporate purposes. Wilson Sonsini Goodrich & Rosati advised Micron on the transaction.

The Wilson Sonsini team representing Micron includes:
Client Highlights

12.10.24

Wilson Sonsini Advises Initial Purchasers in Rule 144A Offering of $1.4 Billion of BILL Convertible Senior Notes
On December 6, 2024, BILL Holdings announced the successful completion of an offering of $1.4 billion aggregate principal amount of 0% convertible senior notes due 2030 in a Rule 144A offering. The offering amount included the exercise in full of the option that BILL had granted to the initial purchasers to purchase up to an additional $150 million of notes. 
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.